Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Here’s the bad news: Auto manufacturing is a notoriously thin-margin industry, and tariffs could tear right through those margins.
The biggest restaurant chain in the world just completed a splashy IPO — and you’ve likely never heard of it.
Eli Lilly last week announced a $27 billion investment in four different domestic manufacturing plants to boost weight-loss drug production.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
On Wednesday, Bloomberg reported that one billion people are watching podcasts on the Google-owned YouTube every month.
European leaders are gearing up for the possibility of a sudden America-shaped hole in the Ukraine defense budget.
Now that semaglutide’s no longer in shortage territory, the FDA said drug-makers have 90 days to wrap up production of their Novo knockoffs.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
De Beers, one of the largest companies in the diamond mining sector, has been battered by the ascendance of cheaper lab-grown gems.
Walmart said Thursday that it made a record $681 billion in sales, and yet its shares had their worst day in three years, tumbling 6.5%.
It took a few extra innings, but Amazon and Main Street Sports Group have finally come to an agreement after a year of circling each other.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.